Sarah Yoo

CD19 CAR T cells following autologous transplantation in poor-risk relapsed and refractory B-cell non-Hodgkin lymphoma

Craig S. Sauter, Brigitte Sénéchal, Isabelle Rivière et al. · Blood · 2019 · 90 citations · Full text

Life Sciences, Hematology, Immunology +16

A risk prediction model for the development of subsequent primary melanoma in a population‐based cohort

Anne Ε. Cust, Caro Badcock, Jessica L. Smith et al. · British Journal of Dermatology · 2019 · 62 citations · Full text

Medicine, Dermatology, Oncology +17

Vitamin D Receptor Gene Haplotypes and Polymorphisms and Risk of Breast Cancer: A Nested Case–Control Study

Lawrence S. Engel, Irene Orlow, Camelia S. Sima et al. · Cancer Epidemiology Biomarkers & Prevention · 2012 · 39 citations · Full text

Life Sciences, Genetics, Molecular Genetics +16

Phase I trial of 19-28z chimeric antigen receptor modified T cells (19-28z CAR-T) post-high dose therapy and autologous stem cell transplant (HDT-ASCT) for relapsed and refractory (rel/ref) aggressive B-cell non-Hodgkin lymphoma (B-NHL).

Craig S. Sauter, Isabelle Rivière, Yvette Bernal et al. · Journal of Clinical Oncology · 2015 · 36 citations

Medicine, Hematology, Oncology +14

A dual-receptor T-cell platform with Ab-TCR and costimulatory receptor achieves specificity and potency against AML

Tao Dao, Guangyan Xiong, Sung Soo Mun et al. · Blood · 2023 · 25 citations · Full text

Life Sciences, Immunology, Molecular Biology +13